Literature DB >> 15808597

Radial flow bioreactor for the creation of bioartificial liver and kidney.

T Iwahori1, N Matsuno, Y Johjima, O Konno, I Akashi, Y Nakamura, K Hama, H Iwamoto, M Uchiyama, T Ashizawa, T Nagao.   

Abstract

A radial flow bioreactor (RFB) is used for a three-dimensional perfusion culture of hepatocellular carcinoma (HCC) cells and renal cells, to create a bioartificial liver and kidney. The cylindrical reactor is filled with porous cellulose microcarrier. RFB can be characterized as a system in which the medium flows from the periphery toward the center of the reactor, thereby delivering an adequate supply of oxygen and nutrients to cells at the center as well as at the periphery. HCC cells incubated in the RFB system at high density maintained viability for long periods of time. Proximal tubular cells (LLC-PK1) as well as HCC cells, but not human immortalized mesangial cells (HMC) were cultured in the RFB for more than 14 days. The mRNA expression of some enzymes involved in the urea cycle, cytochrome P450s in HCC cells, and the 1-alpha-hydroxylase (CYP27B1) in LLC-PK1 cells was higher than that in monolayer cultures. These results suggest that the RFB system composed of HCC cells or renal cells may be useful for a bioartificial liver and kidney.

Entities:  

Mesh:

Year:  2005        PMID: 15808597     DOI: 10.1016/j.transproceed.2005.01.080

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.

Authors:  Mei Niu; Paul Hammond; Robin N Coger
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

2.  Tissue-engineered three-dimensional in vitro models for normal and diseased kidney.

Authors:  Balajikarthick Subramanian; Darya Rudym; Chris Cannizzaro; Ronald Perrone; Jing Zhou; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

3.  Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay.

Authors:  Daniel Mueller; Georg Tascher; Georg Damm; Andreas K Nüssler; Elmar Heinzle; Fozia Noor
Journal:  Cytotechnology       Date:  2012-07-25       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.